"We are aware that many people are waiting for WHO's recommendation for (Bharat Biotech's) Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners," WHO said on Twitter.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.